期刊文献+

两种抗凝方案下房间隔缺损封堵术后纤溶功能动态变化及意义

Effects of the fibrinolytic on two different anticoagulation protocols after transcatheter closure of atrial septal defects
下载PDF
导出
摘要 目的探讨两种抗凝方案下,房间隔缺损(atrial septal defect,ASD)封堵术后纤溶功能的变化规律及其意义。方法 85例成功进行封堵术治疗的ASD患者随机分为延长低分子肝素(prolong low molecular weight heparin,pLWMH)组及低分子肝素(LWMH)组,采用酶联免疫吸附法测定封堵术前、术后即刻、术后第1、2、3、7天及术后第1、3个月血浆组织型纤维溶酶原激活物(tissue plasminogen activator,tPA)、D-D二聚体(D-Dimer)水平。结果封堵术前pLWMH组和LWMH组tPA、D-Dimer无明显差异;术后即刻两组tPA、D-Dimer均较术前明显增加并均达峰值(P<0.05);术后第1、2天两组tPA、D-Dimer均逐渐下降,仍较术前增加;术后第3天两组tPA、D-Dimer均接近术前水平,pLWMH组高于LWMH组,差异无统计学意义。结论无论低分子肝素组还是延长低分子肝素组,ASD封堵术后纤溶功能一过性激活,至术后3 d恢复术前水平。 Objective To investigate the effects of the fibrinolytil on the two different anticoagulation protocols after transcatheter closure of atrial septal defect(ASD) and the significance.Methods Eighty-five ASD patients who successfully underwent transcatheter closure of ASD were randomly divided into a low-molecular-weight heparin group(LMWH group) and a prolonged low-molecular-weight heparin group(pLMWH group).ELISA was applied for detecting the levels of tissue plasminogen activator(tPA) and D-Dimer at different time points including before the operation,immediately after the operation,and 1,2,3,7,30 and 90 d after the operation.Results Before the operation,the levels of tPA and D-D dimer showed no significant difference between the pLMWH group and the LMWH group.The levels of tPA and D-D dimer of the two groups immediately after the operation increased significantly as compared with those before the operation,and reached their peak levels(P0.05).The levels of tPA and D-D dimer declined slightly on 1 d and 2 d after operation(P0.05),then decreased to be close to the baseline on 3 d,and returned to the baseline on 7,30 and 90 d.Conclusion The fibrinolytic system is transiently activated after transcatheter closure of ASD and returns to baseline on day 3 after operation in both the LMWH group and the pLMWH group.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2012年第10期980-982,共3页 Journal of Third Military Medical University
基金 重庆市科技攻关计划项目(CSTC2009AB5033)~~
关键词 低分子肝素 房间隔缺损 封堵术 纤溶 low molecular weight heparin atrial septal defect occlusion fibrinolytic
  • 相关文献

参考文献17

二级参考文献57

  • 1刘蔼如,李家增.交联纤维蛋白及其降解产物[J].中华血液学杂志,1993,14(10):545-546. 被引量:18
  • 2张晨,郭英华,赵慧元.缺血性脑血管病患者血浆D-二聚体和GMP-140含量的变化及临床意义[J].临床神经病学杂志,1996,9(4):202-205. 被引量:9
  • 3脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15752
  • 4邓东安,朱鲜阳,侯传举,韩秀敏.房间隔缺损介入治疗后随诊观察[J].中国介入影像与治疗学,2006,3(5):337-340. 被引量:6
  • 5中华神经科学会 中华神经外科学会.各类脑血管病诊断要点[J].中华神经科杂志,1996,6:379-379.
  • 6MASURA J, GAVORA P, PODNAR T. Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal oecluders [J]. J Am Coll Cardiol, 2005, 45: 505-507.
  • 7DIVCHEV D, SCHAEFER A, FUCHS M, et al. Throw.bus formation on an atrial septal defect closure device: A ease report and review of the literature [J]. European Journal of Echocardiography, 2007, 8: 53-56.
  • 8CLARKE AC, HIRSCH KJ, KELLS CM, et al. Thrombus formation on an atrial septal defect closure device [J]. Can J Cardiol, 2005, 21: 68-70.
  • 9KRUMSDORF U, OSTERMAYER S, BILLINGER K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1 000 consecutive patients[J]. J Am Coll Cardiol, 2004, 43: 302-309.
  • 10WILLCOXSON FE, THOMSON JDIL GIBBS JL Suecessful treatment of left atrial disk thrombus on an Amplatzer atrial septal defect oeeluder with abeiximab and heparin [J]. Heart, 2004, 90: 30-31.

共引文献721

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部